上海佰君生物科技有限公司
- 公司规模:少于50人
- 公司性质:民营公司
- 公司行业:制药/生物工程
公司介绍
上海佰君生物科技有限公司成立于2022年1月,总部位于上海张江高科技园区,注册资本5000万元。公司致力于打造全球领先的生物技术研发服务平台,为全球制药企业和生物公司提供从靶点验证,分子生物学,蛋白表达,抗体表达,生物分析,细胞水平药物筛选,体外药物筛选,体外药物代谢,体内药理药效,体内药物代谢,直到临床前候选药物发现、中美IND申报等一站式药物研发解决方案。
Biometas (Shanghai) Limited,founded in 2022 January, is headquartered in Shanghai Zhangjiang High Tech Park with a registered capital of 50 million RMB. The company is committed to building a world leading bio-focused R&D service platform to provide global pharmaceutical companies and biotechs with one-stop R&D solutions, including target validation, molecular biology, protein expression, antibody production, bioanalytics, cell-based assays, in-vitro assays, ADME, in-vivo pharmacology, in-life PK, PCC identification and China/US IND services.
Biometas (Shanghai) Limited,founded in 2022 January, is headquartered in Shanghai Zhangjiang High Tech Park with a registered capital of 50 million RMB. The company is committed to building a world leading bio-focused R&D service platform to provide global pharmaceutical companies and biotechs with one-stop R&D solutions, including target validation, molecular biology, protein expression, antibody production, bioanalytics, cell-based assays, in-vitro assays, ADME, in-vivo pharmacology, in-life PK, PCC identification and China/US IND services.
联系方式
- 公司地址:中国(上海)自由贸易试验区爱迪生路330号201室
招聘职位
职位名称 | 工作地区 | 更新日期 | 招聘人数 |
---|---|---|---|
细胞生物学研究员 | 上海-浦东新区 | 2024-09-04 | |
蛋白纯化研究员 | 上海-浦东新区 | 2022-06-27 |